BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity

Biochemical and Biophysical Research Communications

Volumn 404, Issue 4, 2011, Pages 903-909

  Hu, Xu Dong ^a   Meng, Qing Hui ^b   Xu, Jia Ying ^a   Jiao, Yang ^a   Ge, Chun Min ^b   Jacob, Asha ^c   Wang, Ping ^c   Rosen, Eliot M ^b   Fan, Saijun ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; BTG2; Prostate cancer; Transcriptional activity

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BTG2 PROTEIN; LEUCINE; MUTANT PROTEIN; PROSTATE SPECIFIC ANTIGEN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; GENE ACTIVATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BINDING; WILD TYPE;

5-ALPHA-DIHYDROPROGESTERONE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; LEUCINE ZIPPERS; MALE; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 79151481567     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.064     Document Type: Article

References (28)

1. Shen M.M., Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev. 2010, 24:1967-2000.
2. Heemers H.V., Tindall D.J. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 2007, 28:778-808.
3. Dubbink H.J., Hersmus R., Verma C.S., et al. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol. Endocrinol. 2004, 18:2132-2150.
4. Litvinov I.V., Chang C., Isaacs J.T. Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-AR. Prostate 2004, 58:319-324.
5. Fan S., Wang J., Ma Y., et al. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 2001, 22:77-87.
6. Fan S., Wang J., Yuan R., et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 1999, 284:1354-1356.
7. Ficazzola M.A., Fraiman M., Gitlin J., et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 2001, 22:1271-1279.
8. Li J., Coetzee G.A. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus. Cancer Res. 2005, 65:8003-8008.
9. Winkler G.S. The mammalian anti-proliferative BTG/Tob protein family. J. Cell Physiol. 2009, 222:66-72.
10. Rouault J.P., Falette N., Guéhenneux F., et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 1996, 14:482-486.
11. Bradbury A., Possenti R., Shooter E.M., et al. Molecular cloning of PC3, A putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc. Natl. Acad. Sci. USA 1996, 88:3353-3357.
12. Fletcher B.S., Lim R.W., Varnum B.C., et al. Structure and expression of TIS21. J. Biol. Chem. 1991, 266:13518-14511.
13. Struckmann K., Schraml P., Simon R., et al. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res. 2004, 64:1632-1638.
14. Kawakubo H., Carey J.L., Brachtel E., et al. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene 2004, 23:8310-8319.
15. Lim I.K. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J. Cancer Res. Clin. Oncol. 2006, 132:417-426.
16. Farioli-Vecchioli S., Tanori M., Micheli L., et al. Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J. 2007, 21:2215-2225.
17. Passeri D., Marcucci A., Rizzo G., et al. Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation. Mol. Cell. Biol. 2006, 26:5023-5032.
18. Lin W.J., Gary J.D., Yang M.C., et al. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem. 1996, 271:15034-15044.
19. Farioli-Vecchioli S., Tanori M., Micheli L., et al. Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J. 2007, 21:2215-2225.
20. Prévôt D., Morel A.P., Voeltzel T., et al. Al., Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway. J. Biol Chem. 2001, 276:9640-9648.
21. Tsui K.H., Hsieh W.C., Lin M.H., et al. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 2008, 68:610-619.
22. Heery D.M., Kalkhoven E., Hoare S. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 2001, 387:733-736.
23. Zhang Y., Jelovac D., Wang X.W., et al. Repression of androgen receptor mediated transcription by the ErbB3-binding protein, Ebp1. Oncogene 2005, 102:9890-9895.
24. Markus S.M., Taneja S.S., Logan S.K. Identification and characterization of ART-27, A novel coactivator for the androgen receptor N terminus. Mol. Biol. Cell 2002, 13:670-682.
25. Nagy L., Kao H.Y., Love J.D., et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 1999, 13:3209-3216.
26. Petre C.E., Wetherill Y.B., Danielsen M., et al. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J. Biol. Chem. 2002, 277:2207-2215.
27. Rosenfeld M.G., Lunyak V.V., Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006, 20:1405-1428.
28. Wolf M., Mousses S., Hautaniemi S., et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 2004, 6:240-247.